EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer

Cili Jifu, Linxia Lu, Jiaxin Ding, Mengjun Lv, Jun Xia, Jingtao Wang, Peijun Wang

Biomolecules · 21.09.2024 · 14 (9) · 1191

DOI: 10.3390/biom14091191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 21.09.2024. Verfasst von Cili Jifu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Ubiquitin Thiolesterase, B7-H1 Antigen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic Medical Research and Translational Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Compared with conventional chemotherapy and targeted therapy, immunotherapy has improved the treatment outlook for a variety of solid tumors, including lung cancer, colorectal cancer (CRC), and melanoma. However, it is effective only in certain patients, necessitating the search for alternative strategies to targeted immunotherapy. The deubiquitinating enzyme USP18 is known to play an important role in various aspects of the immune response, but its role in tumor immunity in CRC remains unclear.

Methods

In this study, multiple online datasets were used to systematically analyze the expression, prognosis, and immunomodulatory role of USP18 in CRC. The effect of USP18 on CRC was assessed via shRNA-mediated knockdown of USP18 expression in combination with CCK-8 and colony formation assays. Finally, molecular docking analysis of USP18/ISG15 and programmed death-ligand 1 (PD-L1) was performed via HDOCK, and an ELISA was used to verify the potential of USP18 to regulate PD-L1.

Results

Our study revealed that USP18 expression was significantly elevated in CRC patients and closely related to clinicopathological characteristics. The experimental data indicated that silencing USP18 significantly promoted the proliferation and population-dependent growth of CRC cells. In addition, high USP18 expression was positively correlated with the CRC survival rate and closely associated with tumor-infiltrating CD8+ T cells and natural killer (NK) cells. Interestingly, USP18 was correlated with the expression of various chemokines and immune checkpoint genes. The results of molecular docking simulations suggest that USP18 may act as a novel regulator of PD-L1 and that its deficiency may potentiate the antitumor immune response to PD-L1 blockade immunotherapy in CRC.

Conclusions

In summary, USP18 shows great promise for research and clinical application as a potential target for CRC immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsUbiquitin ThiolesteraseB7-H1 AntigenHumansPrognosisCell ProliferationCell Line, TumorFemaleMaleGene Expression Regulation, NeoplasticMolecular Docking Simulation

Stichwörter der Autor:innen

PD-L1USP18anticancer immunitycolorectal cancerimmune checkpoint genestumor immune microenvironment

Substanzen

Ubiquitin ThiolesteraseB7-H1 AntigenCD274 protein, humanUSP18 protein, human

Autor:innen und Institutionen

  • College of Basic Medicine, Jiamusi University, Jiamusi 154007, China.
  • College of Public Health, Jiamusi University, Jiamusi 154007, China.

Förderung

  • National Natural Science Foundation of China
  • Basic Medical Research and Translational Team

Zitieren

APA

Jifu, C., Lu, L., Ding, J., Lv, M., Xia, J., Wang, J., & Wang, P. (2024). USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer. Biomolecules, 14(9), 1191. https://doi.org/10.3390/biom14091191

Vancouver

Jifu C, Lu L, Ding J, Lv M, Xia J, Wang J, et al. USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer. Biomolecules. 2024;14(9):1191. doi:10.3390/biom14091191

BibTeX
@article{Jifu2024,
  author = {Jifu, Cili and Lu, Linxia and Ding, Jiaxin and Lv, Mengjun and Xia, Jun and Wang, Jingtao and Wang, Peijun},
  title = {USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {9},
  pages = {1191},
  doi = {10.3390/biom14091191}
}
Kostenlos starten →